FDA giving states authority to approve own coronavirus tests, official says

WASHINGTON (Reuters) – The U.S. Food and Drug Administration on Monday took a step toward speeding the development of coronavirus test kits, agreeing a regulatory change to give states the ability to approve tests developed in laboratories in the states, an administration official said.

The regulatory relief came as President Donald Trump attempts to accelerate the availability of testing for the pandemic as the virus spreads deeper into the United States.

“The purpose is to achieve more rapid testing capacity in the United States,” said the official, who spoke to Reuters on condition of anonymity.

The new policy gives states the option to take responsibility for tests developed and used by laboratories in their states, similar to the action the FDA granted last week to the New York state Department of Health, the official said.